Miconazole - Hill Dermaceuticals

Drug Profile

Miconazole - Hill Dermaceuticals

Alternative Names: Miconzole

Latest Information Update: 04 May 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Hill Dermaceuticals
  • Class Antifungals; Imidazoles; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors; Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Otitis externa

Most Recent Events

  • 20 Apr 2017 Phase-II clinical trials in Otitis externa (In children, In adults, In adolescents, In the elderly) in USA (Otic) (NCT03130738)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top